{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:41:36Z","timestamp":1794357696584,"version":"4.9.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00518"],"award-info":[{"award-number":["PI18\/00518"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01384"],"award-info":[{"award-number":["PI21\/01384"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41433-025-03705-5","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:17:07Z","timestamp":1739909827000},"page":"1526-1531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Blood omega-3 biomarkers, diabetic retinopathy and retinal vessel status in patients with type 1 diabetes"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5038-2794","authenticated-orcid":false,"given":"Aleix","family":"Sala-Vila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Vinagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cof\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Al\u00e9-Chilet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Barraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-8143","authenticated-orcid":false,"given":"Javier","family":"Zarranz-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"3705_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799.","journal-title":"Redox Biol"},{"key":"3705_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","volume":"24","author":"JP SanGiovanni","year":"2005","unstructured":"SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24:87\u2013138.","journal-title":"Prog Retin Eye Res"},{"key":"3705_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408398.2011.565523","volume":"54","author":"Q Ma","year":"2014","unstructured":"Ma Q, Shen JH, Shen SR, Das UN. Bioactive lipids in pathological retinopathy. Crit Rev Food Sci Nutr. 2014;54:1\u201316.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3705_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/antiox9060520","volume":"9","author":"MH Wang","year":"2020","unstructured":"Wang MH, Hsiao G, Al-Shabrawey M. Eicosanoids and oxidative stress in diabetic retinopathy. Antioxidants. 2020;9:520.","journal-title":"Antioxidants"},{"key":"3705_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3945\/ajcn.117.153825","volume":"106","author":"Y Gong","year":"2017","unstructured":"Gong Y, Fu Z, Liegl R, Chen J, Hellstr\u00f6m A, Smith LE. \u03c9-3 and \u03c9-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. Am J Clin Nutr. 2017;106:16\u201326.","journal-title":"Am J Clin Nutr"},{"key":"3705_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10654-017-0338-8","volume":"33","author":"C Dow","year":"2018","unstructured":"Dow C, Mancini F, Rajaobelina K, Boutron-Ruault MC, Balkau B, Bonnet F, et al. Diet and risk of diabetic retinopathy: a systematic review. Eur J Epidemiol. 2018;33:141\u201356.","journal-title":"Eur J Epidemiol"},{"key":"3705_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/IAE.0000000000003745","volume":"43","author":"NL Weir","year":"2023","unstructured":"Weir NL, Guan W, Karger AB, Klein B, Meuer S, Cotch MF, et al. Omega-3 fatty acids are associated with decreased presence and severity of diabetic retinopathy: a combined Analysis of MESA and GOLDR Cohorts. Retina. 2023;43:984\u201391.","journal-title":"Retina"},{"key":"3705_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","volume":"47","author":"L Hodson","year":"2008","unstructured":"Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348\u201380.","journal-title":"Prog Lipid Res"},{"key":"3705_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1\u201355.","journal-title":"Prog Retin Eye Res"},{"key":"3705_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/tvst.9.10.34","volume":"9","author":"M Barraso","year":"2020","unstructured":"Barraso M, Al\u00e9-Chilet A, Hern\u00e1ndez T, Oliva C, Vinagre I, Ortega E, et al. Optical coherence tomography angiography in type 1 diabetes mellitus. Report 1: diabetic retinopathy. Transl Vis Sci Technol. 2020;9:34.","journal-title":"Transl Vis Sci Technol"},{"key":"3705_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-019-0391-8","volume":"19","author":"J Zarranz-Ventura","year":"2019","unstructured":"Zarranz-Ventura J, Barraso M, Al\u00e9-Chilet A, Hernandez T, Oliva C, Gasc\u00f3n J, et al. Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial. BMC Med Imaging. 2019;19:91.","journal-title":"BMC Med Imaging"},{"key":"3705_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1017\/S0007114511000171","volume":"106","author":"A Sala-Vila","year":"2011","unstructured":"Sala-Vila A, Harris WS, Cof\u00e1n M, P\u00e9rez-Heras AM, Pint\u00f3 X, Lamuela-Ravent\u00f3s RM, et al. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. Br J Nutr. 2011;106:425\u201331.","journal-title":"Br J Nutr"},{"key":"3705_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.nutres.2012.06.016","volume":"32","author":"AH Metherel","year":"2012","unstructured":"Metherel AH, Buzikievich LM, Charkhzarin P, Patterson AC, Peel AC, Howorth AM, et al. Omega-3 polyunsaturated fatty acid profiling using fingertip-prick whole blood does not require overnight fasting before blood collection. Nutr Res. 2012;32:547\u201356.","journal-title":"Nutr Res"},{"key":"3705_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3945\/jn.112.158295","volume":"142","author":"WS Harris","year":"2012","unstructured":"Harris WS, Pottala JV, Vasan RS, Larson MG, Robins SJ. Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J Nutr. 2012;142:1297\u2013303.","journal-title":"J Nutr"},{"key":"3705_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677\u20131182.","journal-title":"Ophthalmology"},{"key":"3705_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.783065","volume":"8","author":"C Purdel","year":"2021","unstructured":"Purdel C, Ungurianu A, Margina D. Metabolic and metabolomic insights regarding the omega-3 PUFAs intake in type 1 diabetes mellitus. Front Mol Biosci. 2021;8:783065.","journal-title":"Front Mol Biosci"},{"key":"3705_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1172\/JCI87388","volume":"127","author":"X Bi","year":"2017","unstructured":"Bi X, Li F, Liu S, Jin Y, Zhang X, Yang T, et al. \u03c9-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity. J Clin Investig. 2017;127:1757\u201371.","journal-title":"J Clin Investig"},{"key":"3705_CR18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jama.298.12.1420","volume":"298","author":"JM Norris","year":"2007","unstructured":"Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M, et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007;298:1420\u20138.","journal-title":"JAMA"},{"key":"3705_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00125-013-3106-7","volume":"57","author":"JM Norris","year":"2014","unstructured":"Norris JM, Kroehl M, Fingerlin TE, Frederiksen BN, Seifert J, Wong R, et al. Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity, the Diabetes Autoimmunity Study in the Young. Diabetologia. 2014;57:295\u2013304.","journal-title":"Diabetologia"},{"key":"3705_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00125-017-4280-9","volume":"60","author":"S Niinist\u00f6","year":"2017","unstructured":"Niinist\u00f6 S, Takkinen HM, Erlund I, Ahonen S, Toppari J, Ilonen J, et al. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity. Diabetologia. 2017;60:1223\u201333.","journal-title":"Diabetologia"},{"key":"3705_CR21","first-page":"847","volume":"62","author":"L Hakola","year":"2023","unstructured":"Hakola L, Vuorinen AL, Takkinen HM, Niinist\u00f6 S, Ahonen S, Rautanen J, et al. Dietary fatty acid intake in childhood and the risk of islet autoimmunity and type 1 diabetes: the DIPP birth cohort study. Eur J Nutr. 2023;62:847\u201356.","journal-title":"Eur J Nutr"},{"key":"3705_CR22","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.3390\/nu14235021","volume":"14","author":"J Shah","year":"2022","unstructured":"Shah J, Cheong ZY, Tan B, Wong D, Liu X, Chua J. Dietary intake and diabetic retinopathy: a systematic review of the literature. Nutrients. 2022;14:5021.","journal-title":"Nutrients"},{"key":"3705_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/jcm11010197","volume":"11","author":"A Al\u00e9-Chilet","year":"2021","unstructured":"Al\u00e9-Chilet A, Bernal-Morales C, Barraso M, Hern\u00e1ndez T, Oliva C, Vinagre I, et al. Optical coherence tomography angiography in type 1 diabetes mellitus-report 2: diabetic kidney disease. J Clin Med. 2021;11:197.","journal-title":"J Clin Med"},{"key":"3705_CR24","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/diagnostics11091537","volume":"11","author":"C Bernal-Morales","year":"2021","unstructured":"Bernal-Morales C, Al\u00e9-Chilet A, Mart\u00edn-Pinardel R, Barraso M, Hern\u00e1ndez T, Oliva C, et al. Optical coherence tomography angiography in type 1 diabetes mellitus. Report 4: glycated haemoglobin. Diagnostics. 2021;11:1537.","journal-title":"Diagnostics"},{"key":"3705_CR25","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.3390\/ijerph20065108","volume":"20","author":"R Tatoli","year":"2023","unstructured":"Tatoli R, Lampignano L, Donghia R, Niro A, Castellana F, Bortone I, et al. Retinal microvasculature and neural changes and dietary patterns in an older population in Southern Italy. Int J Environ Res Public Health. 2023;20:5108.","journal-title":"Int J Environ Res Public Health"},{"key":"3705_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108852","volume":"38","author":"S Vujosevic","year":"2024","unstructured":"Vujosevic S, Limoli C, Piccoli G, Costanzo E, Marenzi E, Torti E, et al. A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography. J Diabetes Complic. 2024;38:108852.","journal-title":"J Diabetes Complic"},{"key":"3705_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.survophthal.2021.11.002","volume":"67","author":"G Kalra","year":"2022","unstructured":"Kalra G, Zarranz-Ventura J, Chahal R, Bernal-Morales C, Lupidi M, Chhablani J. Optical coherence tomography (OCT) angiolytics: a review of OCT angiography quantitative biomarkers. Surv Ophthalmol. 2022;67:1118\u201334.","journal-title":"Surv Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03705-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:25:30Z","timestamp":1747657530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03705-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3705"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03705-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Javier Zarranz-Ventura is a member of the Eye editorial board. William S. Harris holds stock in OmegaQuant Analytics, LLC, a laboratory that offers blood fatty acid testing to researchers, healthcare providers and consumers. None of the other authors have any financial interest in the devices employed in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}